Dechra Pharmaceuticals PLC announced that Paul Sandland, acting Chief Financial Officer since April this year, has been appointed as an Executive Director and permanent Chief Financial Officer of the Company with immediate effect. Paul qualified as a Chartered Certified Accountant with KPMG in 2005 and joined Dechra in 2010 as Group Financial Controller. Between 2012 and 2013 Paul was Acting CFO prior to becoming the Group's Dechra Veterinary Products EU finance director, a position he held until April this year.